1 |
PersAF |
14.1 |
N |
Single episode of pAF < 24
hours |
2 |
PersAF |
4.4 |
N |
Recurrence, later controlled on dofetilide until
end of follow-up (14.2 months), which had been ineffective prior to
ablation |
3 |
PersAF |
6.0 |
N |
3 pAF recurrences on CIED until end of follow-up
13.7 months, longest episode 6 minutes |
4 |
LSPAF |
6.8 |
N |
Single 14 hour paroxysmal recurrence on CIED until
end of follow-up 13.3 months |
5 |
PersAF |
10.2 |
Y |
Recurrent persAF 10.2 months, Died 11.5 months
of shock |
6 |
LSPAF |
3.0 |
Y |
Recurrent atypical flutter, underwent redo
ablation without subsequent recurrence out to 19 months
follow-up |
7 |
PersAF |
5.6 |
Y |
Recurrent atypical flutter, underwent redo
ablation without subsequent recurrence out to 8.7 months
follow-up |
8 |
pAF |
3.0 |
Y |
Recurrent atrial fibrillation and emergency
presentations, underwent redo ablation and subsequently AV nodal
ablation |
9 |
pAF |
3.0 |
Y |
Recurrent paroxysmal runs of AF, redo ablation of
right atrial trigger complicated by sinus injury, no subsequent
recurrence for 16.1 months of follow-up |
10 |
pAF |
7.5 |
N |
Recurrent typical atrial flutter, single episode
out to 24 months follow-up. Preceding history of repeated and refractory
emergency presentations prior to ablation. |
11 |
LSPAF |
5.4 |
N |
Presented for single episode of SVT cardioverted
in emergency room over 18.5 months of follow-up |
12 |
PersAF |
16.7 |
N |
Stopped dotetilide shortly before recurrence of
persAF, then resumed with subsequent control |
13 |
PersAF |
7.6 |
N |
Single 90 second AF recurrence on CIED over 10.9
months of follow-up |